Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia

ERJ Open Research

Volumn 1, Issue 1, 2015, Pages

  Aliberti, Stefano ^a   Ramirez, Julio ^b   Cosentini, Roberto ^c   Valenti, Vincenzo ^d   Voza, Antonio ^e   Rossi, Paolo ^f   Stolz, Daiana ^g   Legnani, Delfino ^h   Pesci, Alberto ^a   Richeldi, Luca ^i,j   Peyrani, Paula ^b   Massari, Fernando Maria ^c   Blasi, Francesco ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b University of Louisville School of Medicine   (United States)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85016325078     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00020-2015     Document Type: Article

References (24)

1. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999; 281: 61-66.
2. Aliberti S, Ramirez JA. Cardiac diseases complicating community-acquired pneumonia. Curr Opin Infect Dis 2014; 27: 295-301.
3. Corrales-Medina VF, Musher DM, Wells GA, et al. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012; 125: 773-781.
4. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilatory-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
5. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-summary. Clin Microbiol Infect 2011; 17: Suppl. 6: 1-24.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. Approved standard M100-S14. Wayne, National Committee for Clinical Laboratory Standards, 2004.
7. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007; 116: 2634-2653.
8. Aliberti S, Zanaboni AM, Wiemken T, et al. Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Eur Respir J 2013; 42: 742-749.
9. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 2011; 8: e1001048.
10. Musher DM, Rueda AM, Kaka AS, et al. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007; 45: 158-165.
11. Griffin AT, Wiemken TL, Arnold FW. Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia. Int J Infect Dis 2013; 17: e1125-e1129.
12. Viasus D, Garcia-Vidal C, Manresa F, et al. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013; 66: 27-33.
13. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008; 47: 182-187.
14. Corrales-Medina VF, Musher DM, Shachkina S, et al. Acute pneumonia and the cardiovascular system. Lancet 2013; 381: 496-505.
15. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10: 83-92.
16. Lee RW, Lindstrom ST. A teaching hospital’s experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia. Respirology 2007; 12: 754-758.
17. Nadarajan P, Wilson L, Mohammed B, et al. Compliance in the measurement of CURB-65 in patients with community acquired pneumonia and potential implications for early discharge. Ir Med J 2008; 101: 144-146.
18. Barlow G, Nathwani D, Myers E, et al. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia. J Antimicrob Chemother 2008; 61: 442-451.
19. Kolditz M, Ewig S, Höffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J 2013; 41: 974-984.
20. Aliberti S, Brambilla AM, Chalmers JD, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res 2014; 15: 27.
21. Combes A, Luyt CE, Fagon JY, et al. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35: 146-154.
22. Arnold FW, Wiemken TL, Peyrani P, et al. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males. Eur Respir J 2013; 41: 1135-1140.
23. McAllister DA, Maclay JD, Mills NL, et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J 2012; 39: 1097-1103.
24. Brown AO, Mann B, Gao G, et al. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog 2014; 10: e1004383.